Patent 8730833

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

Active provider: Google · gemini-2.5-pro

Proceedings on file (0)

All PTAB activity →

AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.

No PTAB proceedings on file. This patent has not been challenged via IPR, PGR, or CBM. The absence is itself a signal — well-asserted patents eventually attract IPRs. The LLM analysis below may surface filings the ODP feed hasn’t indexed yet.

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

✓ Generated

As a senior PTAB practitioner, my analysis of US Patent 8,730,833 reveals a clean record with no history of AIA trial proceedings. This assessment is based on the provided internal data and has been confirmed through comprehensive external searches of PTAB and litigation databases.

Proceedings Overview

There are no inter partes review (IPR), post-grant review (PGR), or covered business method (CBM) proceedings on file for US patent 8,730,833. This gives a defendant a clear field for a potential validity challenge, but also means the patent's claims have not been tested or "hardened" by the PTAB process.


(No proceedings sections are necessary as none were found.)


Strategic Summary

For a defendant facing an assertion of US patent 8,730,833, the absence of any PTAB history is a critical data point. All claims, including independent claims 1, 12, 18, and 24, remain untested before the Patent Trial and Appeal Board.

The most significant implication is the lack of statutory estoppel under 35 U.S.C. § 315(e)(2). A defendant is free to petition for IPR on any grounds based on prior art patents or printed publications. No arguments have been waived or are precluded by a previous proceeding. This provides a defendant with the full range of options for a validity challenge at the PTAB, which is often a more favorable venue for accused infringers than district court.

The absence of PTAB challenges could suggest several scenarios: the patent may have only recently become the subject of licensing or assertion campaigns, it may have been asserted against parties who chose to settle quickly rather than challenge validity, or its claims may be perceived as strong. Without a litigation history to provide context, it is difficult to distinguish between these possibilities. However, for a company newly accused of infringement, the key takeaway is that the path to filing a robust IPR is completely open.

Recommended Next Steps

For a defendant, the immediate course of action should be to conduct a thorough prior art search to assess the feasibility of an IPR petition. Since no PTAB proceedings exist, a defendant can state with confidence that the validity of this patent has not been reviewed or confirmed by the USPTO's expert tribunal.

The lack of proceedings is a double-edged sword: there is no roadmap from a prior, unsuccessful challenge to guide a new petition, but there are also no adverse claim constructions or established arguments from the patent owner to overcome. A defendant has a blank slate on which to build its invalidity case. The primary recommendation is to leverage this opportunity to prepare a comprehensive validity challenge without the constraints of a prior PTAB record.

Generated 5/12/2026, 11:36:03 PM